AI-Assisted Design of Nanoantibiotics to Combat Multidrug-Resistant Organisms

The rise of multidrug-resistant (MDR) organisms poses a substantial challenge to global health,severely limiting the therapeutic options available and exacerbating mortality rates. Traditionalantibiotics are increasingly ineffective against these resistant pathogens due to the mechanisms theyemploy to neutralize or avoid the action of antibiotics. Nanoantibiotics, engineered from nanoparticleswith antimicrobial properties or functionalized with antimicrobial agents, offer an innovative approachto combat these resistant microorganisms. However, the design of effective nanoantibiotics requiresan in-depth understanding of the interactions between nanoparticles and microbial cells, as well as aprecise optimization of the physicochemical properties of nanoparticles. Artificial intelligence (AI) hasemerged as a powerful tool in accelerating and enhancing the design of nanoantibiotics by enablingpredictive modeling of nanoparticle behavior and guiding the development of optimizednanomaterials. This article explores the application of AI in the design of nanoantibiotics, includingthe methodologies used, challenges, and future directions for AI-assisted nanomedicine in addressingMDR organisms.